- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00148629
Treatment and Prevention of Severe Anemia in Pregnant Zanzibari Women
Preventing Unnecessary Blood Transfusions in Pregnant Women in Africa Through Effective Primary Health Care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a clinic-randomized trial involving 8 antenatal clinics and approximately 2500 women. The specific aims are:
Aim 1: To evaluate the efficacy of the current internationally recommended standard of care, as described by the WHO, for the prevention of severe anemia among pregnant Zanzibari women. This aim will be achieved through a pre-post intervention comparison.
Aim 2: To evaluate the efficacy of an enhanced treatment regimen in comparison to the current standard of care to prevent severe anemia among pregnant Zanzibari women.
Aim 3: To evaluate the efficacy of the current internationally recommended standard of care, as described by the WHO, for the cure of severe anemia among pregnant Zanzibari women.
Aim 4: To evaluate the efficacy of an enhanced treatment regimen in comparison to the current standard of care to cure severe anemia among pregnant Zanzibari women.
Study Type
Enrollment
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Zanzibar
-
Wawi, Zanzibar, Tanzania
- Public Health Laboratory "Ivo de Carneri"
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant woman
Exclusion Criteria:
- Not a permanent resident of the community
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Incidence of severe anemia (Hb < 7 g/dL)
|
Cure of severe anemia
|
Secondary Outcome Measures
Outcome Measure |
---|
Neonatal morbidity
|
Neonatal mortality
|
Infant birth weight
|
Blood loss during delivery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: James M Tielsch, PhD, The Johns Hopkins Bloomberg School of Public Health
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Hematologic Diseases
- Body Weight
- Birth Weight
- Anemia
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Enzyme Inhibitors
- Antineoplastic Agents
- Tubulin Modulators
- Antimitotic Agents
- Mitosis Modulators
- Antiparasitic Agents
- Antinematodal Agents
- Anthelmintics
- Mebendazole
- Piperazine
- Piperazine citrate
- DMP 777
Other Study ID Numbers
- UCHS 02-10-030
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)United Kingdom, Belgium, Netherlands, France, United States, Germany, Hungary, Italy
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Abdelwahed, Mai Mahmoud Mohamed, M.D.UnknownAnemia During PregnancyEgypt
-
University of California, DavisInstituto Mexicano del Seguro Social; Thrasher Research Fund; Mexican National... and other collaboratorsCompleted
-
Incyte CorporationActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Belgium, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom
-
Peking Union Medical College HospitalRecruiting
-
Alexion PharmaceuticalsWithdrawnWarm Autoimmune Hemolytic AnemiaUnited States
Clinical Trials on multivitamin, mebendazole
-
Johns Hopkins Bloomberg School of Public HealthAga Khan UniversityCompleted
-
Regina EsiovwaLagos State University; Nigerian Institute of Medical Research; University of... and other collaboratorsUnknown
-
Texas Tech UniversityNutraceutical CorporationCompletedMineral AbsorptionUnited States
-
Kaneka Americas Holding Inc.KGK Science Inc.Completed
-
NephrianUnknownInflammation | Hyperphosphatemia | Renal DiseaseUnited States
-
Do Vitamins Inc.Nutrasource Pharmaceutical and Nutraceutical Services, Inc.Completed
-
Martin-Luther-Universität Halle-WittenbergCompleted
-
University of California, DavisCompleted
-
Northumbria UniversityVitabioticsUnknownStress | AgingUnited Kingdom
-
National Institute of Diabetes and Digestive and...Office of Dietary Supplements (ODS)CompletedCardiovascular Disease | Death | Chronic Kidney DiseaseUnited States, Canada, Brazil